Titan Medical Inc
TSX:TMD

Watchlist Manager
Titan Medical Inc Logo
Titan Medical Inc
TSX:TMD
Watchlist
Price: 0.045 CAD 2 268.42% Market Closed
Market Cap: 686.5m CAD

Relative Value

The Relative Value of one TMD stock under the Base Case scenario is 0.005 CAD. Compared to the current market price of 0.045 CAD, Titan Medical Inc is Overvalued by 88%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TMD Relative Value
Base Case
0.005 CAD
Overvaluation 88%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
4
vs Industry
0
Median 3Y
25.5
Median 5Y
29.2
Industry
2.4
vs History
vs Industry
47
Median 3Y
-13
Median 5Y
-25.6
Industry
22.5
vs History
vs Industry
53
Median 3Y
-9.1
Median 5Y
-18.4
Industry
14.4
vs History
vs Industry
42
Median 3Y
-8.8
Median 5Y
-16.5
Industry
20.9
vs History
11
vs Industry
0
Median 3Y
9.8
Median 5Y
17.6
Industry
2.3
vs History
4
vs Industry
0
Median 3Y
22
Median 5Y
28.1
Industry
2.6
vs History
vs Industry
89
Median 3Y
0
Median 5Y
0
Industry
5.2
vs History
vs Industry
57
Median 3Y
-8.7
Median 5Y
-11.5
Industry
11.9
vs History
vs Industry
54
Median 3Y
-8.3
Median 5Y
-11.3
Industry
16.4
vs History
vs Industry
58
Median 3Y
-8.6
Median 5Y
-16.6
Industry
14.6
vs History
vs Industry
47
Median 3Y
-8.4
Median 5Y
-16
Industry
18.1
vs History
vs Industry
53
Median 3Y
-138.5
Median 5Y
-106.2
Industry
1.9

Multiples Across Competitors

TMD Competitors Multiples
Titan Medical Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Titan Medical Inc
TSX:TMD
686.5m CAD 521.5 -98.2 -227.3 -215.4
US
Abbott Laboratories
NYSE:ABT
230.8B USD 5.4 16.5 21.8 30.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
169B USD 18.5 64.8 50.4 60.5
US
Boston Scientific Corp
NYSE:BSX
156.6B USD 8.5 62.5 35 48.3
US
Stryker Corp
NYSE:SYK
149.2B USD 6.3 51.1 25.3 30.5
IE
Medtronic PLC
NYSE:MDT
118.2B USD 3.5 25.4 13.9 20
DE
Siemens Healthineers AG
XETRA:SHL
53.3B EUR 2.3 24.5 13.8 19.3
US
Becton Dickinson and Co
NYSE:BDX
55.7B USD 2.6 34.7 13.3 24
US
IDEXX Laboratories Inc
NASDAQ:IDXX
51.5B USD 12.8 52.2 37.6 41.7
US
Edwards Lifesciences Corp
NYSE:EW
47.5B USD 8.4 11.5 25.4 27.8
US
Resmed Inc
NYSE:RMD
42.4B USD 8.2 30.3 21.8 24.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Titan Medical Inc
TSX:TMD
Average EV/EBITDA: 25.8
Negative Multiple: -227.3
N/A N/A
US
Abbott Laboratories
NYSE:ABT
21.8
13%
1.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
50.4
25%
2
US
Boston Scientific Corp
NYSE:BSX
35
22%
1.6
US
Stryker Corp
NYSE:SYK
25.3
12%
2.1
IE
Medtronic PLC
NYSE:MDT
13.9
7%
2
DE
Siemens Healthineers AG
XETRA:SHL
13.8
14%
1
US
Becton Dickinson and Co
NYSE:BDX
13.3
11%
1.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
37.6
12%
3.1
US
Edwards Lifesciences Corp
NYSE:EW
25.4
12%
2.1
US
Resmed Inc
NYSE:RMD
21.8
10%
2.2
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Titan Medical Inc
TSX:TMD
Average EV/EBIT: 32.8
Negative Multiple: -215.4
N/A N/A
US
Abbott Laboratories
NYSE:ABT
30.7
23%
1.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
60.5
27%
2.2
US
Boston Scientific Corp
NYSE:BSX
48.3
33%
1.5
US
Stryker Corp
NYSE:SYK
30.5
16%
1.9
IE
Medtronic PLC
NYSE:MDT
20
16%
1.2
DE
Siemens Healthineers AG
XETRA:SHL
19.3
19%
1
US
Becton Dickinson and Co
NYSE:BDX
24
27%
0.9
US
IDEXX Laboratories Inc
NASDAQ:IDXX
41.7
13%
3.2
US
Edwards Lifesciences Corp
NYSE:EW
27.8
13%
2.1
US
Resmed Inc
NYSE:RMD
24.8
12%
2.1